Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 85 citing articles:

Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Xiaolu Guo, Naidi Yang, Wenhui Ji, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Closed Access | Times Cited: 317
Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy
Javad Sharifi‐Rad, Cristina Quispe, Jayanta Kumar Patra, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 176
Recent advances in active targeting of nanomaterials for anticancer drug delivery
Bijaideep Dutta, K.C. Barick, P. A. Hassan
Advances in Colloid and Interface Science (2021) Vol. 296, pp. 102509-102509
Closed Access | Times Cited: 155
Smart materials for drug delivery and cancer therapy
Yao Yang, Weiwei Zeng, Ping Huang, et al.
View (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 146
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 122
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
Jing Liu, Horacio Cabral, Peng Mi
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115239-115239
Closed Access | Times Cited: 54
Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug delivery applications
Mehrab Pourmadadi, Mohammad Mahdi Eshaghi, Shima Ostovar, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104357-104357
Closed Access | Times Cited: 49
Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 17
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 2
The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy
Shangui Liu, Abdur Rauf Khan, Xiaoye Yang, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 1-20
Closed Access | Times Cited: 96
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yuma Yamada, Satrialdi Satrialdi, Mitsue Hibino, et al.
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 187-209
Closed Access | Times Cited: 90
The crosstalk between HIFs and mitochondrial dysfunctions in cancer development
Xingting Bao, Jinhua Zhang, Guomin Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 87
Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment
Jingbo Qin, Ningqiang Gong, Zhihuan Liao, et al.
Nanoscale (2021) Vol. 13, Iss. 15, pp. 7108-7118
Closed Access | Times Cited: 71
Emerging nanomedicines of paclitaxel for cancer treatment
Qin Chen, Shu Xu, Shuo Liu, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 280-294
Closed Access | Times Cited: 65
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
Yi Zhun Zhu, Na Xie, Yilu Chai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 47
Construction of a dual-responsive dual-drug delivery platform based on the hybrids of mesoporous silica, sodium hyaluronate, chitosan and oxidized sodium carboxymethyl cellulose
Dan Shao, Qiang Gao, Yanshan Sheng, et al.
International Journal of Biological Macromolecules (2022) Vol. 202, pp. 37-45
Closed Access | Times Cited: 45
Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
Beibei Guo, Yan Qu, Yinping Sun, et al.
Bioactive Materials (2023) Vol. 25, pp. 61-72
Open Access | Times Cited: 37
Application of molecular dynamics simulation in self-assembled cancer nanomedicine
Xueli Xu, Ao Liu, Shuangqing Liu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche
Chunyu Xia, Wenjing Bai, Tao Deng, et al.
Acta Biomaterialia (2023) Vol. 158, pp. 708-724
Closed Access | Times Cited: 25
Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions
Ghulam Mustafa Channa, Dilawar Hassan, Gustavo Ruiz-Pulido, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104494-104494
Closed Access | Times Cited: 25
Recent advances in natural small molecules as drug delivery systems
Shiyao Fu, Xin Yang
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 21, pp. 4584-4599
Closed Access | Times Cited: 24
Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
Solomon Habtemariam
Molecules (2020) Vol. 25, Iss. 6, pp. 1426-1426
Open Access | Times Cited: 53
A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents
Suliman Khan, Arif Hussain, Farnoosh Attar, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112531-112531
Open Access | Times Cited: 52
Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
Yan Liang, Ze-Yun Liu, Pingyu Wang, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 396-409
Closed Access | Times Cited: 45
Smart Nanotherapeutics and Lung Cancer
Mohammad Doroudian, Mohammad H. Azhdari, Nima Goodarzi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1972-1972
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top